Maraganore will step down at the end of 2021, Alnylam said in a surprising announcement Thursday. Yvonne Greenstreet, the company’s president and chief operating officer, will take over the reins.
SAN DIEGO, Jan. 5, 2021 /PRNewswire/ -- A study conducted by Millennium Health and published in the Journal of Addiction Medicine reveals a dangerous increase in definitive urine drug test positivity for methamphetamine alone and in combination with other substances. The analysis included two million patient specimens collected between January 1, 2014, and December 31, 2019, and found:
Jardiance (empagliflozin), GLYXAMBI (empagliflozin/linagliptin), SYNJARDY® XR (empagliflozin/metformin ER) : Boehringer Ingelheim vs. MSN Labs
Velcade (Bortezomib): Millennium Pharmaceuticals vs Hetero Labs Limited
Jardiance (empagliflozin), GLYXAMBI (empagliflozin/linagliptin), SYNJARDY® XR (empagliflozin/metformin ER) : Boehringer Ingelheim vs. Zydus Pharms
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Sun Pharma
Enforcement Report - Week of February 14, 2018
The company is restructuring to cut costs. As part of that process, it is laying off about half of its staff. Most of the job cuts are expected to be finished by March 2018. Because of the cuts, OvaScience expects to show savings in the second quarter of the year, with one-time costs of about $1 million to $1.5 million.
The immunotherapy company has hired Hugh Cole as its new CBO and head of corporate development, Jounce announced Tuesday afternoon. The move comes about eight months after Jounce went public.
OSAKA, Japan –Takeda Pharmaceutical Company (TKPYY) and London-based venture capital firm Abingworth LLP are investing a combined $100 million into GammaDelta Therapeutics to develop that company’s T cell platform, which is based on the unique properties of gamma delta (y?) T cells derived from human tissues.